Industry recognition. See more on the awards page.
At ICON, we are at the forefront of innovation in clinical research, harnessing the power of Artificial Intelligence to transform the way trials are conducted.
Our AI solutions are designed to accelerate trial timelines, improve data accuracy, optimise resource management, and ensure compliance—all while maintaining the highest ethical standards. With our AI-driven approach, we are committed to delivering faster, smarter, and more reliable outcomes that benefit sponsors, patients, and healthcare providers for a healthier world.
AI champions
Our AI literacy program and network of AI Champions identify areas for greater efficiencies within the organisation.
Data scientists and engineers
Data scientists and engineers drive robust strategies, testing, development and impactful solutions.
Award-winning solutions
Multi-award winning innovative and pragmatic solutions delivering measurable and impactful value to our clients.
Our AI solutions
To provide a comprehensive understanding of our AI capabilities, we ve categorised our solutions into three main areas.
Accelerating trial execution
Our solutions in this category focus on streamlining the clinical trial process, from site selection to patient enrolment and study startup. These tools significantly reduce trial timelines and improve overall trial performance.
One Search
Identify the right sites and investigators faster, reducing time to site identification and improving patient recruitment success rates.
ICONex
Quickly identify key opinion leaders in all therapeutic areas including rare diseases, accelerating study design and startup.
Cassandra
Predict post-marketing study requirements early, allowing for proactive planning and reducing the risk of regulatory delays.
Enhancing data and resource management
These solutions are designed to improve the quality and efficiency of data management and resource allocation, ensuring that clinical trials run smoothly and effectively.
iSubmit
Automate document management for clinical trials, ensuring compliance and reducing the burden on study teams.
MRT COA
Stay updated with the latest clinical outcome assessments, providing comprehensive intelligence to optimise trial designs.
FORWARD+
Optimise your resource management with precise forecasting, targeted information and seamless automation.
Optimising operational efficiency
Our operational efficiency solutions are designed to transform the way teams interact with data and streamline critical processes, leading to faster and more informed decision making.
SmartDraft
Use AI to streamline site contract drafting, reduce negotiation cycles and accelerate site activation.
OMR AI Navigation Assistant
Gain quick, actionable insights from complex operational metrics with AI powered natural language queries.
Why choose AI at ICON?
-
proven results
Our AI solutions have been recognised with industry awards and have consistently delivered measurable improvements in trial performance. -
governance
We prioritise responsible AI use, backed by our AI Ethics Committee, ensuring that our solutions adhere to the highest standards of data privacy and security. -
innovation
We are continually pushing the boundaries of what's possible in clinical research to make trials more efficient, safe and insightful.
AI ethics committee
Our AI ethics committee ensures ICON is fully compliant and that we act ethically and with integrity. We will continue to provide the highest standard of data quality and protect and preserve our stakeholders’ individual privacy, confidentiality, and intellectual property rights.
-
Media article: Using clinical decision support tools to facilitate decision-making In Precision Medicine
To fulfill its promise precision medicine requires accurate decision support tools, especially to streamline biomarker testing so that the appropriate targeted therapies are prescribed.
-
Media article: Validating Value Data: AI & Outcomes
The application of AI and machine learning in establishing a treatment’s value proposition is still a relatively new concept in pharma. Katya Svoboda, Taneesha Chawla, and Tanvi Ahuja, authors of the ICON whitepaper, The Impact of Artificial Intelligence on Outcomes Based Contracting discuss the challenges and opportunities in the October 2019
-
Media article: Can Digital Technologies and AI improve R&D productivity enough to restore ROI?
A thought leadership article authored by Tom O’Leary and featured in BioSpectrum Asia October 2019 edition, exploring what can be done to help ensure return on investment in clinical trials.
-
Media article: Hasta la vista, maybe? Terminating the Hollywood view of AI in pharma
Read this Pharmaceutical Market Europe (PME) article to explore featured commentary from ICON expert Tom O’Leary on the use of AI in the pharmaceutical sector.
-
Media article: The Digital Trial: How Technology Is Changing Trial Design, Start-Up And Close-Out
In this Clinical Informatics News article, featuring commentary from ICON expert Marie McCarthy, leveraging technology to accelerate study close-out is further discussed.
-
Media article: A New Horizon
A PharmaTimes article featuring commentary from Tom O’Leary on the future of AI in healthcare.
-
Blog: mHealth Devices Allow for Better Treatments and Clinical Outcomes
Benefits include better, more personalised, treatment and improved clinical outcomes, with fewer clinic visits and greater independence for patients.
-
Blog: The power of AI to transform clinical trials
Artificial intelligence (AI) technology, combined with big data, hold the potential to solve many key clinical trial challenges.
Get started with AI at ICON
Ready to transform your clinical trials with AI? Contact us today to learn how ICON's AI solutions can accelerate your research and deliver better outcomes.